Latest News

Actinium Pharmaceuticals to Highlight First-in-Human Phase 1 Study of ATNM-400 a HER3-Targeted Non-PSMA Radiotherapy in Prostate Cancer at ESMO 2026

Oracle Expands Marketplace to Unlock New Partner Growth Opportunities

Vertiv to Participate in Upcoming Investor Conference

Alpha Announces Preliminary Financial Results for Third Quarter 2026

Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026

Clear Channel Outdoor and OUTFRONT Team Up with Million Mammograms Challenge to Encourage Early Breast Cancer Screening

ImPact Biotech Reports Encouraging Early Clinical Results From Phase 1 Study of Padeliporfin VTP in Pancreatic Cancer, with Seven Previously Unresectable Patients Undergoing Surgical Resection Following Treatment

Humacyte at ASN Kidney Week: Phase 3 Trial Built for Women Shows ATEV Advantage Over Fistula, Getting Patients Off Catheters Months Sooner

Winnebago Industries Announces Intention to Nominate Jay L. Johnson to Board of Directors at 2026 Annual Meeting

Dayforce to Acquire Ribbon AI Inc. to Advance Agentic Recruiting